跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
BUDAMAX AQUEOUS NASAL SPRAY budesonide 64 microgram/actuation spray bottle - TGA Drug Approval Details
Approvals
/
TGA
/
BUDAMAX AQUEOUS NASAL SPRAY budesonide 64 microgram/actuation spray bottle
Approved
STANDARD
BUDAMAX AQUEOUS NASAL SPRAY budesonide 64 microgram/actuation spray bottle
Johnson & Johnson Pacific Pty Ltd
🇦🇺 Therapeutic Goods Administration
Approval Date
May 30, 2025
Approval ID
335afbf4bd425faf
Company
Johnson & Johnson Pacific Pty Ltd
Type
Standard
Approval Details
Approval Id
335afbf4bd425faf
Product Name
BUDAMAX AQUEOUS NASAL SPRAY budesonide 64 microgram/actuation spray bottle
Artg Id
75659
Artg Name
BUDAMAX AQUEOUS NASAL SPRAY budesonide 64 microgram/actuation spray bottle
Sponsor
Johnson & Johnson Pacific Pty Ltd
Company Detail Path
/organization/johnson-and-johnson-pacific-pty-ltd
Artg Date
2000-08-24
Registration Type
Medicine
Therapeutic Good Type
Medicine
Licence Status
A
Licence Category
RE
Consumer Medicine Info
http://www.ebs.tga.gov.au/ebs/picmi/picmirepository.nsf/pdf?OpenAgent=&id=CP-2017-CMI-02655-1
Product Information
http://www.ebs.tga.gov.au/ebs/picmi/picmirepository.nsf/pdf?OpenAgent=&id=CP-2017-PI-02654-1
Active Ingredients
Approved
Quick Info
Agency
TGA
Country
🇦🇺
Approval Date
May 30, 2025
Approval ID
335afbf4bd425faf
Type
Standard
Back to TGA Approvals